momo-T/FIF Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : momo-T/FIF

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: zeta1961 who wrote (4169)	3/23/2006 6:27:50 PM
From: Biomaven	Read Replies (2) of 12215

conduct additional studies of the drug to see if any new cases of Steven Johnson's Syndrome or SJS occur If you think the rate may be as much as one in a thousand, then you probably need a study of something like 10,000 to measure this. Not going to happen in my view. One in a thousand to one in ten-thousand is estimated to be what the rate is for anti-epileptic drugs (AEDs). Lots of drugs are implicated in SJS (rarely), including some OTC drugs and many antibiotics. If the rate here really is 1 in a 1,000, I agree that is indeed much too high for a "lifestyle" drug used by children. But I suspect we will never know what the true rate is, and I suspect the drug is dead for this indication. Lesson? Don't develop lifestyle drugs for children... Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next